PortalPublikationenThe European experience with use of clozapine.

The European experience with use of clozapine.

Standard

The European experience with use of clozapine. / Naber, Dieter; Hippius, H.

in: Hosp Community Psychiatry, Jahrgang 41, Nr. 8, 8, 1990, S. 886-890.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Naber, D & Hippius, H 1990, 'The European experience with use of clozapine.', Hosp Community Psychiatry, Jg. 41, Nr. 8, 8, S. 886-890. <http://www.ncbi.nlm.nih.gov/pubmed/1976107?dopt=Citation>

APA

Naber, D., & Hippius, H. (1990). The European experience with use of clozapine. Hosp Community Psychiatry, 41(8), 886-890. [8]. http://www.ncbi.nlm.nih.gov/pubmed/1976107?dopt=Citation

Vancouver

Naber D, Hippius H. The European experience with use of clozapine. Hosp Community Psychiatry. 1990;41(8):886-890. 8.

Bibtex

@article{f3cfeef3ffd146619b22e95a7bc6971e,
title = "The European experience with use of clozapine.",
abstract = "The efficacy and adverse effects of clozapine for patients who cannot be treated with conventional neuroleptics were evaluated by means of a retrospective chart review. The review showed that 85 percent of 503 inpatients experienced slight to nearly complete reduction in symptoms. Adverse effects occurred in 59 percent of patients, although only 7 percent had side effects severe enough to warrant discontinuation of the drug. Data for 70 outpatients treated with clozapine showed that the rate of rehospitalization was significantly lower than before treatment with the drug. These findings agree with those of other European studies and suggest that when hematological and other variables are carefully controlled, the benefits of clozapine therapy outweigh the risks.",
author = "Dieter Naber and H Hippius",
year = "1990",
language = "Deutsch",
volume = "41",
pages = "886--890",
number = "8",

}

RIS

TY - JOUR

T1 - The European experience with use of clozapine.

AU - Naber, Dieter

AU - Hippius, H

PY - 1990

Y1 - 1990

N2 - The efficacy and adverse effects of clozapine for patients who cannot be treated with conventional neuroleptics were evaluated by means of a retrospective chart review. The review showed that 85 percent of 503 inpatients experienced slight to nearly complete reduction in symptoms. Adverse effects occurred in 59 percent of patients, although only 7 percent had side effects severe enough to warrant discontinuation of the drug. Data for 70 outpatients treated with clozapine showed that the rate of rehospitalization was significantly lower than before treatment with the drug. These findings agree with those of other European studies and suggest that when hematological and other variables are carefully controlled, the benefits of clozapine therapy outweigh the risks.

AB - The efficacy and adverse effects of clozapine for patients who cannot be treated with conventional neuroleptics were evaluated by means of a retrospective chart review. The review showed that 85 percent of 503 inpatients experienced slight to nearly complete reduction in symptoms. Adverse effects occurred in 59 percent of patients, although only 7 percent had side effects severe enough to warrant discontinuation of the drug. Data for 70 outpatients treated with clozapine showed that the rate of rehospitalization was significantly lower than before treatment with the drug. These findings agree with those of other European studies and suggest that when hematological and other variables are carefully controlled, the benefits of clozapine therapy outweigh the risks.

M3 - SCORING: Zeitschriftenaufsatz

VL - 41

SP - 886

EP - 890

IS - 8

M1 - 8

ER -